-0.00116464529768625 -0.000287653356657499 -0.000638450133069001 0.00158326278420374 0.00269411924284011 0.003512645054467 0.00342494586036404 0.00327878053685922
Sign Up Today X
Thanks for submitting the form.
Stockreport

Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection? [Forbes]

Alphabet Inc. - Class C Capital Stock (GOOG)  More Company Research Source: Forbes
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
(NASDAQ : AMGN) has seen a solid 9% rise in a week, outperforming the broader S&P500 index, up 1.5%. The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported last week. The company reported revenues of $7.45 billion and adjusted earnings of $3.96, compared to the consensus estimates of $7.45 billion and $3.88, respectively. In this note, we discuss Amgen's stock performance, key takeaways from its recent results, and valuation. Firstly, let us look at Amgen's stock performance. AMGN stock has shown gains of 30% from levels of $230 in early January 2021 to around $300 now, vs. an increase of about 40% for the S&P 500 over this roughly three-year period. However, the increase in AMGN stock has been far from consistent. Returns for the stock were -2% in 2021, 17% in 2022, and 10% in 2023. In comparison, returns for the S&P 500 have been 27% in 2021, -19% in 2022, and 24% in 2023 — indicating that AMGN underperformed the [Read more]
IMPACT SNAPSHOT EVENT TIME: GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GOOG alerts
from News Quantified
GOOG
NEWS
GOOG
Earnings
GOOG
Analyst Actions
GOOG
SEC Filings
Stockreport

Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection? [Forbes]

Alphabet Inc. - Class C Capital Stock  (GOOG) 
More Company Research Source: Forbes
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
(NASDAQ : AMGN) has seen a solid 9% rise in a week, outperforming the broader S&P500 index, up 1.5%. The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported last week. The company reported revenues of $7.45 billion and adjusted earnings of $3.96, compared to the consensus estimates of $7.45 billion and $3.88, respectively. In this note, we discuss Amgen's stock performance, key takeaways from its recent results, and valuation. Firstly, let us look at Amgen's stock performance. AMGN stock has shown gains of 30% from levels of $230 in early January 2021 to around $300 now, vs. an increase of about 40% for the S&P 500 over this roughly three-year period. However, the increase in AMGN stock has been far from consistent. Returns for the stock were -2% in 2021, 17% in 2022, and 10% in 2023. In comparison, returns for the S&P 500 have been 27% in 2021, -19% in 2022, and 24% in 2023 — indicating that AMGN underperformed the [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS